Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?

Descripción del Articulo

Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The ide...

Descripción completa

Detalles Bibliográficos
Autores: Moreno Muñoz, Roberth Nixon, Vergara Trujillo, Richard Adrián, Guevara Lizarazo, German Andrés, Brett Cano, Patrick Junior, León Cuervo, Dalila Andrea, Puerta Lidueñas, Adriana Marcela, Sarmiento Figueroa, Mariana, Ortega Sierra, Michael
Formato: artículo
Fecha de Publicación:2023
Institución:Universidad de San Martín de Porres
Repositorio:Horizonte médico
Lenguaje:español
inglés
OAI Identifier:oai:horizontemedico.usmp.edu.pe:article/2245
Enlace del recurso:https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245
Nivel de acceso:acceso abierto
Materia:stroke
risk
carotid artery diseases
surgical procedures
operative
therapeutics
accidente cerebrovascular
riesgo
enfermedades de las arterias carótidas
procedimientos quirúrgicos operativos
terapéutica
id REVHM_a95497873d7427e3fc07cd1808b3bde6
oai_identifier_str oai:horizontemedico.usmp.edu.pe:article/2245
network_acronym_str REVHM
network_name_str Horizonte médico
repository_id_str
dc.title.none.fl_str_mv Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente?
title Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
spellingShingle Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
Moreno Muñoz, Roberth Nixon
stroke
risk
carotid artery diseases
surgical procedures
operative
therapeutics
accidente cerebrovascular
riesgo
enfermedades de las arterias carótidas
procedimientos quirúrgicos operativos
terapéutica
title_short Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
title_full Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
title_fullStr Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
title_full_unstemmed Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
title_sort Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?
dc.creator.none.fl_str_mv Moreno Muñoz, Roberth Nixon
Vergara Trujillo, Richard Adrián
Guevara Lizarazo, German Andrés
Brett Cano, Patrick Junior
León Cuervo, Dalila Andrea
Puerta Lidueñas, Adriana Marcela
Sarmiento Figueroa, Mariana
Ortega Sierra, Michael
author Moreno Muñoz, Roberth Nixon
author_facet Moreno Muñoz, Roberth Nixon
Vergara Trujillo, Richard Adrián
Guevara Lizarazo, German Andrés
Brett Cano, Patrick Junior
León Cuervo, Dalila Andrea
Puerta Lidueñas, Adriana Marcela
Sarmiento Figueroa, Mariana
Ortega Sierra, Michael
author_role author
author2 Vergara Trujillo, Richard Adrián
Guevara Lizarazo, German Andrés
Brett Cano, Patrick Junior
León Cuervo, Dalila Andrea
Puerta Lidueñas, Adriana Marcela
Sarmiento Figueroa, Mariana
Ortega Sierra, Michael
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv stroke
risk
carotid artery diseases
surgical procedures
operative
therapeutics
accidente cerebrovascular
riesgo
enfermedades de las arterias carótidas
procedimientos quirúrgicos operativos
terapéutica
topic stroke
risk
carotid artery diseases
surgical procedures
operative
therapeutics
accidente cerebrovascular
riesgo
enfermedades de las arterias carótidas
procedimientos quirúrgicos operativos
terapéutica
description Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.
publishDate 2023
dc.date.none.fl_str_mv 2023-09-13
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245
10.24265/horizmed.2023.v23n3.11
url https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245
identifier_str_mv 10.24265/horizmed.2023.v23n3.11
dc.language.none.fl_str_mv spa
eng
language spa
eng
dc.relation.none.fl_str_mv https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1534
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1574
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1643
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1658
https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1705
dc.rights.none.fl_str_mv Derechos de autor 2023 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2023 Horizonte Médico (Lima)
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/xml
text/html
application/pdf
text/xml
dc.publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
publisher.none.fl_str_mv Universidad de San Martín de Porres. Facultad de Medicina Humana
dc.source.none.fl_str_mv Horizonte Médico (Lima); Vol. 23 No. 3 (2023): Julio-Setiembre; e2245
Horizonte Médico (Lima); Vol. 23 Núm. 3 (2023): Julio-Setiembre; e2245
Horizonte Médico (Lima); v. 23 n. 3 (2023): Julio-Setiembre; e2245
2227-3530
1727-558X
reponame:Horizonte médico
instname:Universidad de San Martín de Porres
instacron:USMP
instname_str Universidad de San Martín de Porres
instacron_str USMP
institution USMP
reponame_str Horizonte médico
collection Horizonte médico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1847257318138314752
spelling Stroke risk in patients with asymptomatic carotid atherosclerosis: should it be treated medically or surgically?Riesgo de accidente cerebrovascular en pacientes con aterosclerosis carotídea asintomática: ¿se debe tratar médicamente o quirúrgicamente?Moreno Muñoz, Roberth Nixon Vergara Trujillo, Richard Adrián Guevara Lizarazo, German Andrés Brett Cano, Patrick Junior León Cuervo, Dalila Andrea Puerta Lidueñas, Adriana Marcela Sarmiento Figueroa, Mariana Ortega Sierra, Michaelstrokeriskcarotid artery diseasessurgical proceduresoperativetherapeutics accidente cerebrovascularriesgoenfermedades de las arterias carótidasprocedimientos quirúrgicos operativosterapéutica Cerebrovascular disorders remain the leading cause of neurological morbidity and mortality in the world, representing one of the pathological entities responsible for the greatest burden of disease worldwide. Carotid atherosclerosis or stenosis is a potential risk factor for ischemic stroke. The identification and strict follow-up of this condition are essential in the secondary prevention of complications through primary care and the specialized treatment of cardiometabolicrisk. However, depending on this risk and/or presence of symptoms, definitive treatment is necessary. Currently, there is controversy as to whether asymptomatic carotid stenosis is better to be treated medically or surgically. Consideringthe significance of such entity, this review aims to analyze recent evidence on the risk of ischemic stroke in the case of asymptomatic carotid atherosclerosis among adults, as well as the potential benefit of the surgical vs. pharmacologicaltreatment for this condition. For this purpose, a literature search for publications up to 2023 was carried out in PubMed, ScienceDirect, Web of Science and MEDLINE databases. It was shown that there is a significant risk of stroke associated with asymptomatic carotid stenosis (> 10 % approximately), even in patients with active antiplatelet and lipid-lowering therapy. Out of all those who receive medical treatment, around 80 % had a five-year survival rate. However, stenosisprogression occurs on average in more than 60 % of the cases and is significant. On the other hand, carotid stenting and endarterectomy are curative interventions. Nevertheless, these procedures involve a higher risk compared to the medicaltherapy during the peri- and postoperative period, as well as 30 days afterwards, due to the occurrence or recurrence of stroke, acute myocardial infarction or death from any cause. Despite this, the use of endarterectomy has shown superiorlong-term benefits concerning these same outcomes. Thus, evidence regarding the superiority of surgical treatment compared to pharmacological treatment for asymptomatic carotid atherosclerosis or stenosis is heterogeneous. However, it seems that surgical treatment, specifically endarterectomy, could have a significant impact on the occurrence orrecurrence of ipsilateral stroke and death in the long term but with controversial peri- and postoperative outcomes.Los desórdenes cerebrovasculares siguen siendo la primera causa de morbilidad y mortalidad neurológica en el mundo, representando una de las entidades patológicas que genera mayor carga de enfermedad a nivel global. La aterosclerosis, o estenosis carotídea, es un potencial factor de riesgo para el ictus isquémico. La identificación y seguimiento estricto de esta condición son esenciales en la prevención secundaria de complicaciones a través de la atención primaria y el manejo especializado del riesgo cardiometabólico. No obstante, dependiendo de este riesgo y/o la presencia de sintomatología, es necesario realizar un manejo definitivo. Actualmente, existe controversia sobre si es mejor tratar la estenosis carotídea asintomática, ya sea médica o quirúrgicamente. Teniendo en cuenta la relevancia de esta entidad, el objetivo de esta revisión consiste en analizar la evidencia reciente sobre el riesgo de ictus isquémico en la aterosclerosis carotídea asintomática en adultos, y el potencial beneficio del manejo quirúrgico vs. farmacológico de esta condición. Para esto, se llevó a cabo una búsqueda bibliográfica en las bases de datos PubMed, ScienceDirect, Web of Science y MEDLINE, hasta el año 2023. Se evidenció que el riesgo de ictus asociado a estenosis carotídea asintomática es significativo (>10 %, aproximadamente), incluso en aquellos con terapia antiplaquetaria e hipolipemiante activa. En aquellos con manejo médico, la supervivencia a cinco años es alrededor del 80 %. Sin embargo, la progresión de la estenosis sucede en promedio en más del 60 % de los casos, y es significativa. Por el contrario, el stent carotídeo y la endarterectomía son intervenciones resolutivas. Pero existe un riesgo mayor comparado con la terapia médica, el cual se atribuye al periodo peri- y posoperatorio, así como a 30 días de aparición o recurrencia del ictus, infarto agudo de miocardio o muerte por cualquier causa; aunque el uso de la endarterectomía ha demostrado beneficios superiores a largo plazo en cuanto a estos mismos desenlaces. Entonces, la evidencia es heterogénea en cuanto a la superioridad del tratamiento quirúrgico comparado con la terapia farmacológica en el manejo de la aterosclerosis o estenosis carotídea asintomática. Sin embargo, parece ser que el manejo quirúrgico, específicamente la endarterectomía, podría impactar significativamente sobre la aparición o recurrencia del ictus ipsilateral y muerte a largo plazo, pero con resultados controversiales peri- y postoperatorios. Universidad de San Martín de Porres. Facultad de Medicina Humana2023-09-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmltext/htmlapplication/pdftext/xmlhttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/224510.24265/horizmed.2023.v23n3.11Horizonte Médico (Lima); Vol. 23 No. 3 (2023): Julio-Setiembre; e2245Horizonte Médico (Lima); Vol. 23 Núm. 3 (2023): Julio-Setiembre; e2245Horizonte Médico (Lima); v. 23 n. 3 (2023): Julio-Setiembre; e22452227-35301727-558Xreponame:Horizonte médicoinstname:Universidad de San Martín de Porresinstacron:USMPspaenghttps://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1534https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1574https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1643https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1658https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2245/1705Derechos de autor 2023 Horizonte Médico (Lima)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:horizontemedico.usmp.edu.pe:article/22452023-09-13T16:00:13Z
score 13.085615
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).